Home

JBM Research

JBM Health economics

JBM Communications

How we work

About JBM

What's new?

JBM Publications

 


Email enquiry

 

 

 

 

 

 

 

 

 
 

 JBM Publications

  1. Belsey JD, Pittard JB, Rao S et al. Self blood glucose monitoring in type 2 diabetes. A financial impact analysis based on UK primary care. Int J Clin Pract 2009;63(3):439-448. PubMed abstract.

  2. Candy D, Belsey J. Macrogol (polyethylene glycol) based laxatives in children with functional constipation and faecal impaction: A systematic review. Arch Dis Childhood 2009;94(2):156-160. PubMed abstract.

  3. Belsey J, Epstein O, Heresbach, D. Systematic review: adverse event reports for oral sodium phosphate and polyethylene glycol. Aliment Pharmacol Ther 2008 Aug 24. [Epub ahead of print].

  4. Belsey J. Acute phosphate nephropathy--comment on Sica et al. Am J Gastroenterol 2008;103:800. PubMed abstract.

  5. Belsey J. Trend in left handed presidents may be due to chance. BMJ 2008;337:a915. PubMed abstract.

  6.  Belsey JD. Switch strategies in the management of hypertension: A cost minimisation analysis of angiotensin receptor blocker based regimen. Curr Med Res Opin 2008;24:581-589. PubMed abstract.

  7.  Belsey J, de Lusignan S, van Vlymen J, Chan T, Hague N. Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy. Curr Med Res Opin 2008;24:2703-2709. PubMed abstract.

  8. Belsey J, de Lusignan S, Chan T, van Vlymen J, Hague N. Abnormal lipids in high-risk patients achieving cholesterol targets: a cross-sectional study of routinely collected UK general practice data. Curr Med Res Opin 2008;24:2551-2560. PubMed abstract.

  9. Belsey J, Krishnarajah G. Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta-analysis. Diabetes Obes Metab 2008;10 Suppl 1:1-7. PubMed abstract.

  10. Pearse RM, Belsey JD, Cole JN, Bennett ED. Effect of dopexamine infusion on mortality following major surgery: individual patient data meta-regression analysis of published clinical trials. Crit Care Med 2008;36:1323-1329. PubMed abstract.

  11. Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in type 2 diabetes. Diabetic Med 2008;25:245-254. PubMed abstract.

  12. Belsey J, Epstein O, Heresbach D. Systematic review: oral bowel preparation for colonoscopy. Aliment Pharmacol Ther 2007;25:373-384. PubMed abstract.

  13. Gallacher SJ, Gallagher AP, McQuillian C, Mitchell PJ, Dixon T. The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int 2007;18:185-192. PubMed abstract.

  14. Belsey J. Principles of pharmaceutical marketing. In: Eds Edwards LD et al. Principles and practice of pharmaceutical medicine 2nd ed. Wiley London 2007.

  15. de Lusignan S, Hague N, Belsey J, et al. The 'rule of halves' still applies to the management of cholesterol in cardiovascular disease: 2002-2005. Brit J Cardiol 2006;13:145-153.

  16. Belittlement and harassment of medical students: seems to achieve focus. BMJ 2006;333:920. PubMed abstract.

  17. Beringer T, Heyburn G, Finch M et al. Prevalence of vitamin D inadequacy in Belfast following fragility fracture. Curr Med Res Opin 2006;22:101-105. PubMed abstract.

  18. Bayly JR, Hollands RD, Riordan-Jones SE et al. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study. Curr Med Res Opin 2006;22:131-137. PubMed abstract.

  19. Ryan P, Dixon T. Prevalence of vitamin D inadequacy in patients attending a metabolic bone clinic in Medway. Curr Med Res Opin 2006;22:211-216. PubMed abstract.

  20. Dixon T, Mitchell P, Beringer T et al. An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Curr Med Res Opin 2006;22:405-415. PubMed abstract.

  21. de Lusignan S, Belsey J, Hague N, Dhoul N, van Vlymen J. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study. J Public Health (Oxf) 2006;28:361-369. PubMed abstract.

  22. Bellavance A, Belsey J. Triptan preference in acute migraine management: A retrospective review of patient records from a Canadian clinic population. Headache Care 2006;3:39-43.

  23. Gallacher SJ, McQuillian C, Harkness M et al. Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures. Curr Med Res Opin 2005;21:1355-1361. PubMed abstract.

  24. Moniz C, Dixon T, Dew T. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin 2005;21:1891-1894. PubMed abstract.

  25. De Lusignan S, Belsey J, Hague N et al. End-digit preference in blood pressure recordings of patients with ischaemic heart disease in primary care. J Hum Hypertens 2004;18:261-265. PubMed abstract.

  26. Belsey JD. Cost effectiveness of oral triptan therapy: A trans-national comparison based on a meta-analysis of randomised controlled trials. Curr Med Res Opin 2004;20:659-669. PubMed abstract.

  27. Belsey JD. Non-steroidal anti-inflammatory induced upper gastrointestinal event rates in patients awaiting joint replacement in the United Kingdom. An epidemiologically-based burden of disease model. Curr Med Res Opin 2003;19:306-312. PubMed abstract.

  28. Belsey J, Adelman JU. Meta-analysis methodology: The battle continues. Headache 2003;43:1119-1121. PubMed abstract.

  29. Belsey J, Adelman JU. Updated meta-analysis of oral triptan therapy for migraine: Number needed to treat (NNT) and relative cost to achieve 2-hour pain-free status. Headache 2003;43:565 (Abst S114).

  30. Adelman JU, Belsey J. Meta-analysis of oral triptan therapy for migraine: Number needed to treat and relative cost to achieve relief within 2 hours. J Managed Care Pharm 2003;9:45-52. PubMed abstract.

  31. Belsey J. Primary care workload in the management of chronic pain. A retrospective cohort study using a GP database to identify resource implications for UK primary care. J Med Econ 2002;5:39-50.

  32. Belsey JD. The clinical and financial impact of oral triptans – an updated meta-analysis. J Med Econ 2002;5:79-89.

  33. Belsey J. Effect of varying pooling methods and analytical techniques on the qualitative results of triptan meta-analyses. Headache 2002;42:408.

  34. Belsey J. Me-graine or my-graine: An etymological headache. Headache 2002;42:445 (Abst S83).

  35. Belsey J. Clinical efficacy and cost-effectiveness of oral triptans: An updated meta-analysis incorporating data for almotriptan. Cephalalgia 2001;21:407 (Abst P2-K5)

  36. Belsey J. Reconciling effectiveness and tolerability in oral triptan therapy: A quantitative approach to decision making in migraine management. J Clin Res 2001;4:105-125.

  37. Belsey JD. The clinical and financial impact of oral triptans in the management of migraine in the UK: A systematic review. J Med Econ 2000;3:35-47.

  38. Phillips C, Belsey J, Shindler J. Flora pro.activ: A clinical and financial impact analysis. J Med Econ 2000;3:61-76.

  39. Belsey J. The clinical and financial impact of oral triptans in the management of migraine in the UK: A systematic review. Cephalalgia 2000;20:412 (Abst 365).

  40.  Belsey JD. Clinical outcomes in osteoporosis: The fracture intervention trial in context. Medical Dialogue 1997;480.